A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 682
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MPGN
Long Form : membranoproliferative glomerulonephritis
No. Year Title Co-occurring Abbreviation
2020 ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal. ACTH, FSGS, IgAN, LN, MCD, MN, NS
2020 Chronic Chagastic cardiomyopathy associated with membranoproliferative glomerulonephritis: Report of an autopsy case. Tr. cruzi
2020 Evaluation of the children with C3 glomerulopathy. C3G, IF, Ig
2020 Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits. HUVS
2020 Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy. aHUS, DGKE
2020 Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy. ---
2020 Membranoproliferative glomerulonephritis related to a streptococcal infection in a girl with IgA deficiency: a case report. MZR, PSL
2020 Rituximab use in adult glomerulopathies and its rationale. AAV, FSGS, IMN, KDIGO, LN, MCD, RCTs, RTX
2020 Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement. CIN, FSGS, IgAN, MN, RA
10  2020 Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. DN, FSGS, HSPN, LN, MCD, NS, ORG, PGN, SGN
11  2020 [C3 glomerulopathy and MPGN - current classification]. C3G, IC-MPGN
12  2019 A Case of Prostate Cancer Presenting with Rash. HCV, MC
13  2019 A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection. ---
14  2019 Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy. C3G, C3NeFs, IC, IC-MPGN
15  2019 C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial. IQR
16  2019 Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center. AP, IC
17  2019 Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft. PGNMIGD
18  2019 Diffuse membranoproliferative glomerulonephritis with focal sclerosis and renal amyloidosis in an adult male with autosomal dominant dystrophic epidermolysis bullosa: a case report. EB
19  2019 Effectiveness of cryofiltration and mizoribine combination with oral steroid therapy in a patient with membranoproliferative glomerulonephritis due to essential cryoglobulinemia. MZR, PSL
20  2019 Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies. FSGS, GN, IgAN, LN, MCD, TMA
21  2019 Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome. DDS, DMS
22  2019 Immune-complex glomerulonephritis in cats: a retrospective study based on clinico-pathological data, histopathology and ultrastructural features. CIN, CKD, FIV, ICGN, IRIS, MeGN, MGN, non-ICGN, SBP, UPC
23  2019 Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study. ESKD
24  2019 Paeoniflorin Inhibits Mesangial Cell Proliferation and Inflammatory Response in Rats With Mesangial Proliferative Glomerulonephritis Through PI3K/AKT/GSK-3beta Pathway. GSK, HMCs, IGF-1, LPS, PI3K
25  2019 Pathological findings of progressive renal involvement in a patient with TAFRO syndrome. VEGF
26  2019 Prevalence rates of histopathologic subtypes associated with steroid resistance in childhood nephrotic syndrome in Sub-Saharan Africa: a systematic review. FSGS, MCN, MesPGN, MN, SRNS, SSA
27  2019 Recurrence of membranoproliferative glomerulonephritis post transplant - Is this mere recurrence of pattern or recurrence of disease? ---
28  2019 Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review. iMCD, TMA, VEGF
29  2019 TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review. IL, TMA, VEGF
30  2019 [Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities]. IF, MGRS
31  2018 A case of Graves' disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis. BUN, CRP, HD, TSH
32  2018 Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis. ANCA, GN, MPA
33  2018 Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. CI, CKD, HCV, HR
34  2018 Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015. eGFR, J-RBR
35  2018 Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts. PGNMID, SCr
36  2018 Complement your knowledge with a rare cause of pauci-immune glomerulonephritis. ANCA, EM, GN, IF, PIGN
37  2018 Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy. C3G, CI, ICGN, IF, IP
38  2018 Evaluation of cases of membranoproliferative glomerulonephritis according to newer classification: A retrospective record-based study. DIF, EM
39  2018 Fundus changes in type III membranoproliferative glomerulonephritis: a case report. CNV, OCT, RPE
40  2018 Genetic analysis of the complement pathway in C3 glomerulopathy. C3GN, DDD
41  2018 Hepatitis C Virus-associated Membranoproliferative Glomerulonephritis Treated with Directly Acting Antiviral Therapy. CG, HCV
42  2018 Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil. ---
43  2018 IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. IgA, IgAN
44  2018 Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series. C3G, C3GN, DDD, eGFR, ESRD, RAAS
45  2018 Membranoproliferative glomerulonephritis in Russian population. eGFR, Ig, iMPGN
46  2018 Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report. ALP, CD, CRP, IL-6, TS
47  2018 Mixed cryoglobulinemic membranoproliferative glomerulonephritis due to monoclonal gammopathy of undetermined significance: A case report. HCV
48  2018 Modified scanning electron microscopy reveals pathological crosstalk between endothelial cells and podocytes in a murine model of membranoproliferative glomerulonephritis. EF, mSEM, PFP, VEGF-A, WT1
49  2018 Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents. C3G, ESRD, IC-MPGN
50  2018 Overexpression of toll-like receptor 9 correlates with podocyte injury in a murine model of autoimmune membranoproliferative glomerulonephritis. BXSB, IFNG, IL1B, TLRs, TNFA, Yaa
51  2018 Recurrence of native kidney disease after kidney transplantation. FSGS, IgAN, MN
52  2018 Recurrent allograft C3 glomerulonephritis and unsuccessful eculizumab treatment. ---
53  2018 Renal-limited Cryoglobulinemic Vasculitis: Two Case Reports. CV, RTX
54  2018 Rituximab treatment for immune-complex-mediated membranoproliferative glomerulonephritis. ---
55  2018 Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report. ---
56  2018 Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN. C3G, C3NeFs, IC
57  2017 A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant. DAAs, HCV
58  2017 Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases? aHUS, IF, TMA
59  2017 Case Report of Spontaneous Remission of Biopsy-Proven Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis. ---
60  2017 Clinical and morphologic spectrum of renal involvement in patients with HBV-associated cryoglobulinaemia. HBV
61  2017 Clinicopathological Analysis of Glomerular Disease of Adult Onset Nephrotic Syndrome in an Indian Cohort- A Retrospective Study. FSGS, MCD, MSGN
62  2017 Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report. DAAs, DCV/ASV, HCV
63  2017 Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis. FSGS, GN, ICGN, IgAN, IgMN, MCD, MEFV, MGN, MsPGN
64  2017 Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement. aHUS
65  2017 Immune Complex Membranoproliferative Glomerulonephritis Associated with Transjugular Intrahepatic Portosystemic Shunts in Alcoholic Cirrhosis: Two Case Reports. TIPS
66  2017 Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab. CLL
67  2017 Membranoproliferative Glomerulonephritis Associated with a Human Immunodeficiency Virus Infection. HIV
68  2017 Membranoproliferative Glomerulonephritis in Pregnancy. ---
69  2017 MPGN and mixed cryoglobulinemia in a patient with hepatitis C - new treatment implications and renal outcomes. DAA, HCV, SVR
70  2017 Profile of glomerular diseases associated with hepatitis B and C: A single-center experience from India. MN
71  2017 Renal involvement in lysinuric protein intolerance: contribution of pathology to assessment of heterogeneity of renal lesions. LPI
72  2017 Retinal findings in membranoproliferative glomerulonephritis. ---
73  2017 Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. C3GN, DDD
74  2017 Role of Immunofluorescence in Adult Onset Nephrotic Syndrome-A Study in a Tertiary Care Centre of Western India. IF, MCD
75  2017 Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative Glomerulonephritis. DAAs, HCV
76  2017 The role of PTEN up-regulation in suppressing glomerular mesangial cells proliferation and nephritis pathogenesis. ATSN, GMC, RMC
77  2017 [Changes in the complement system in membranoproliferative glomerulonephritis]. C3GP, LN, TCC
78  2016 A histopathological outlook on nephrotic syndrome: A pediatric perspective. FSGS, INS, MGN, MSGN, non-MCD, NS
79  2016 Clinical and pathological considerations on renal diseases in patients with chronic viral hepatitis. HBV, HCV, IgA
80  2016 Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. 24-hUPE, CR, FSGS, KD, LEF, LM, MMF, PR, RASI, RBC, SCr, TW
81  2016 Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. C3G, Ig-MPGN
82  2016 Complement related kidney diseases: Recurrence after transplantation. HUS
83  2016 Cryoglobulinemia in a patient with chronic lymphocytic leukemia - A case report and review of literature of renal involvement in CLL. CLL/SLL, Ig
84  2016 Immune mediated crescentic MPGN secondary to HBV infection: A rare presentation for a common infection. HBV
85  2016 Intestinal Intravascular Large B-cell Lymphoma Mimicking Ulcerative Colitis with Secondary Membranoproliferative Glomerulonephritis. IVLBCL, UC
86  2016 Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis. APKD, GN
87  2016 Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series. ---
88  2016 Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification. CGN, ESRD, ICGN
89  2016 Pathology of membranoproliferative glomerulonephritis (MPGN): past, present and future. ---
90  2016 Proteinuria rebound in IgA nephropathy associated with obesity-related glomerulopathy. IgAN, ORG
91  2016 Rapid isolation of pure Complement Factor H from serum for functional studies by the use of a monoclonal antibody that discriminates FH from all the other isoforms. aHUS, AMD, FH
92  2016 Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. ---
93  2016 Rituximab use in adult primary glomerulopathy: where is the evidence? FSGS, IgAN, IMN, RCTs
94  2016 Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy. C3GN
95  2016 SHEDDING LIGHT ON FUNDUS DRUSEN ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: BREAKING STEREOTYPES OF TYPES I, II, AND III. ---
96  2016 Streptococcal Infection-related Nephritis (SIRN) Manifesting Membranoproliferative Glomerulonephritis Type I. NAPlr, SIRN
97  2015 A case of membranoproliferative glomerulonephritis and AA amyloidosis complicated with pulmonary nontuberculous mycobacterial infection. NTM
98  2015 A case of membranoproliferative glomerulonephritis associated with curved fibril deposition. FGN, HBV, HCV, ITG
99  2015 Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting. ---
100  2015 Clinicopathological features of membranoproliferative glomerulonephritis under a new classification. CM, IM